# Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients

> **NCT02203630** · PHASE4 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Septic Shock
- Sepsis
- Shock
- Tachycardia
- Arrhythmia

## Interventions

- **DRUG:** Phenylephrine
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT02203630
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Slow enrollment; Lack of support and equipoise
- **Last updated:** 2018-06-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203630, "Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02203630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*